ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Endometrial Cancer
Ovarian Epithelial Carcinoma
Breast Cancer
Cancer
Fallopian Tube Cancer
Non-Small-Cell Lung Carcinoma
Colorectal Cancer

Ovarian Cancer trials near Austin, TX, USA:

A Study of Avutometinib (VS-6766) V. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer with and Without a KRAS Mutation (RAMP 201)

the safety and efficacy of avutometinib (VS-6766) monotherapy and in combination with defactinib in subjects with recurrent Low-Grade Serous Ovarian...

Active, not recruiting
Low Grade Ovarian Serous Adenocarcinoma
Ovarian Cancer
Drug: avutometinib (VS-6766) and defactinib
Drug: avutometinib (VS-6766)

Phase 2

Verastem

Austin, Texas, United States and 46 other locations

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

Austin, Texas, United States and 20 other locations

study is to compare how well Rina-S works against platinum-resistant ovarian cancer compared to chemotherapy drugs that are already ...

Active, not recruiting
Platinum-resistant Ovarian Cancer
Drug: Topotecan
Drug: Gemcitabine

Phase 3

Genmab
Genmab

Austin, Texas, United States and 176 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...

Enrolling
Low Grade Serous Ovarian Cancer
Drug: Defactinib
Drug: Letrozole

Phase 3

Verastem

Austin, Texas, United States and 105 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

Austin, Texas, United States and 73 other locations

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess the s...

Enrolling
Primary Peritoneal Cancer
Epithelial Ovarian Cancer
Drug: Mirvetuximab Soravtansine
Drug: Bevacizumab

Phase 2

AbbVie
AbbVie

Austin, Texas, United States and 71 other locations

HWK-007-101 is a multicenter, open-label, first-in-human (FIH) Phase 1 study evaluating HWK-007, a protein tyrosine kinase 7 (PTK7)-targeted antibody...

Enrolling
Endometrial Cancer
Ovarian Cancer Metastatic Recurrent
Drug: HWK-007

Phase 1

Whitehawk Therapeutics, Inc.

Austin, Texas, United States and 11 other locations

Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...

Active, not recruiting
Ovarian Neoplasms
Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma
Drug: Dostarlimab-Placebo
Drug: Standard of care

Phase 3

Tesaro
Tesaro

Austin, Texas, United States and 181 other locations

as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high fola...

Active, not recruiting
Peritoneal Cancer
Fallopian Tube Cancer
Drug: Bevacizumab
Drug: Mirvetuximab soravtansine plus Bevacizumab

Phase 3

AbbVie
AbbVie

Austin, Texas, United States and 270 other locations

Locations recently updated

The purpose of this study is to evaluate INCB123667 versus investigator's choice of chemotherapy in participants with platinum-resistant ovarian...

Enrolling
Ovarian Cancer
Drug: INCB123667
Drug: Investigator's choice of chemotherapy

Phase 3

Incyte
Incyte

Austin, Texas, United States and 197 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems